Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Cardiology Journal

Volumn 17, Issue 1, 2010, Pages 49-56

  Piestrzeniewicz, Katarzyna ^a   Łuczak, Katarzyna ^a   Maciejewski, Marek ^a   Drozdz, Jarosław ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adiponectin; Left ventricular remodeing; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE WALL MOTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTERIOR WALL MYOCARDIAL INFARCTION; BLOOD GLUCOSE; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OSMOLAR CONCENTRATION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 75749097317     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Cohn JN, Ferrari R, Sharpe N; on behalf of an International Forum on Cardiac Remodeling. Cardiac remodeling - concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol, 2000; 35: 569-582.
2. French BA, Kramer CM. Mechanisms of post-infarct left ventricular remodeling. Drug Discov Today Dis Mech, 2007; 4: 185-196.
3. Tani S, Nagao K, Watanabe I et al. Increasingly well-preserved left ventricular function in hospital survivors with acute myocardial infarction: Effect of early and complete reperfusion strategy on left ventricular remodeling. Circ J, 2007; 71: 180-185.
4. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation, 1993; 87: 755-763.
5. Yang Y, Gao R, Tian J et al. Beneficial effects of early coronary reperfusion on left ventricular remodeling and systolic function in patients with acute myocardial infarction. Chin Med J (Engl), 1998; 111: 142-146.
6. Łoboz-Grudzień K, Kowalska A, Brzezińska B, Sokalski L, Jaroch J. Early predictors of adverse left ventricular remodelling after myocardial infarction treated by primary angioplasty. Cardiol J, 2007; 14: 238-245.
7. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol, 1995; 25: 567-573.
8. Savoye C, Equine O, Tricot O et al.; REmodelage VEntriculaire Study Group. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Am J Cardiol, 2006; 98: 1144-1149.
9. Ennezat PV, Darchis J, Lamblin N et al.; REVE Investigators. Left ventricular remodeling is associated with the severity of mitral regurgitation after inaugural anterior myocardial infarction-optimal timing for echocardiographic imaging. Am Heart J, 2008; 155: 959-965.
10. Coletta C, Sestili A, Seccareccia F et al. Influence of contractile reserve and inducible ischaemia on left ventricular remodelling after acute myocardial infarction. Heart, 2003; 89: 1138-1143.
11. Bolognese L, Carrabba N, Parodi G et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation, 2004; 109: 1121-1126.
12. Uehara K, Nomura M, Ozaki Y et al. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction. Heart Vessels, 2003; 18: 67-74.
13. Bauters C, Ennezat PV, Tricot O et al.; REVE Investigators. Stress hyperglycaemia is an independent predictor of left ventricular remodeling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J, 2007; 28: 546-552.
14. Nicolau JC, Maia LN, Vitola JV, Mahaffey KW, Machado MN, Ramires JA. Baseline glucose and left ventricular remodeling after acute myocardial infarction. J Diabetes Complications, 2007; 21: 294-299.
15. Guerre-Millo M. Adiponectin: An update. Diabetes Metab, 2008; 34: 12-18.
16. Okui H, Hamasaki S, Ishida S et al. Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides. Int J Cardiol, 2008; 126: 53-61.
17. Yang H, Zhang R, Mu H, Li M, Yao Q, Chen C. Adiponectin promotes endothelial cell differentiation from human peripheral CD14+ monocytes in vitro. J Cell Mol Med, 2006; 10: 459-469.
18. Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001; 103: 1057-1063.
19. Liang KW, Sheu WH, Lee WL et al. Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris. Int J Cardiol, 2008; 129: 76-80.
20. Chandrasekar B, Boylston WH, Venkatachalam K, Webster NJ, Prabhu SD, Valente AJ. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMPK activation and IKK/NF-kappaB/PTEN suppression. J Biol Chem, 2008; 283: 24889-24898.
21. Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation, 2000; 102: 1296-1301.
22. Kobayashi H, Ouchi N, Kihara S et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res, 2004; 94: e27-e31.
23. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem, 2003; 278: 45021-45026.
24. Shibata R, Sato K, Pimentel DR et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat Med, 2005; 11: 1096-1103.
25. Tao L, Gao E, Jiao X et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/ nitrative stress. Circulation, 2007; 115: 1408-1416.
26. Shibata R, Izumiya Y, Sato K et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol, 2007; 42: 1065-1074.
27. Kojima S, Funahashi T, Otsuka F et al. Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction. Atherosclerosis, 2007; 194: 204-213.
28. Morishima I, Sone T, Okumura K et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol, 2000; 36: 1202-1209.
29. Takahashi T, Hiasa Y, Ohara Y et al. Usefulness of coronary flow reserve immediately after primary coronary angioplasty for acute myocardial infarction in predicting long-term adverse cardiac events. Am J Cardiol, 2007; 100: 806-811.
30. Shibata R, Numaguchi Y, Matsushita K et al. Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction. Am J Cardiol, 2008; 101: 1712-1715.
31. Bolognese L, Neskovic AN, Parodi G et al. Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications. Circulation, 2002; 106: 2351-2357.
32. Modena MG, Rossi R, Sgura FA, Muia N Jr, Molinari R, Mattioli G. Early predictors of late dilation and remodeling after thrombolized anterior transmural myocardial infarction. Modena Clin Cardiol, 1997; 20: 28-34.
33. Giannuzzi P, Temporelli PL, Bosimini E et al. Heterogeneity of left ventricular remodeling after acute myocardial infarction: Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy. Am Heart J, 2001; 14: 131-138.
34. Sejersten M, Maynard C, Clemmensen P; DANAMI-2 Investigators. Effects of abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI-2 trial). Acute Card Care, 2006; 8: 75-82.
35. Iwakura K, Ito H, Ikushima M et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol, 2003; 41: 1-7.
36. Kersten JR, Toller WG, Tessmer JP, Pagel PS, Warltier DC. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol, 2001; 281: H2097-H2104.
37. Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warltier DC. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol. 1998; 275: H721-725.
38. Lavi S, Kapeliovich M, Gruberg L et al. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: Impact on long-term prognosis. Int J Cardiol, 2008; 123: 117-122.
39. Carrabba N, Valenti R, Parodi G, Santoro GM, Antoniucci D. Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction. Circulation, 2004; 110: 1974-1979.
40. Kadri Z, Danchin N, Yaur L et al. Major impact of admission glycaemia on 30-day and one year mortality in non-diabetic patients admitted for myocardial infarction: Results from the nationwide French USIC 2000 study. Heart, 2006; 92: 910-915.
41. Kojima S, Funahashi T, Sakamoto T et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart, 2003; 89: 667-668.
42. Nishizawa H, Shimomura I, Kishida K et al. Androgens decrease plasma adiponectin, an insulin sensitizing adipocyte-derived protein. Diabetes, 2002; 51: 2734-2741.